(Q46758053)

English

Treatment of mild to moderate seborrhoeic dermatitis with MAS064D (Sebclair), a novel topical medical device: results of a pilot, randomized, double-blind, controlled trial

scientific article published in March 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18269596

Treatment of mild to moderate seborrhoeic dermatitis with MAS064D (Sebclair), a novel topical medical device: results of a pilot, randomized, double-blind, controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18269596

1 reference

based on heuristic

inferred from title

seborrhoeic dermatitis

1 reference

based on heuristic

inferred from title

author name string

S Veraldi

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18269596

A Menter

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18269596

M Innocenti

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18269596

publication date

1 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18269596

Journal of the European Academy of Dermatology and Venereology

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18269596

22

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18269596

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18269596

290-296

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18269596

Superficial fungal infections: an update on pityriasis versicolor, seborrheic dermatitis, tinea capitis, and onychomycosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02404.X

21 January 2018

Dandruff and seborrhoeic dermatitis: causes and management

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02404.X

21 January 2018

Fast, noninvasive method for molecular detection and differentiation of Malassezia yeast species on human skin and application of the method to dandruff microbiology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02404.X

21 January 2018

The prevalence of Malassezia yeasts in patients with atopic dermatitis, seborrhoeic dermatitis and healthy controls.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02404.X

21 January 2018

Seborrhoeic dermatitis is not caused by an altered immune response to Malassezia yeast

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02404.X

21 January 2018

Prescribing practices for seborrheic dermatitis vary with the physician's specialty: implications for clinical practice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02404.X

21 January 2018

Tacrolimus 0.1% ointment for seborrhoeic dermatitis: an open-label pilot study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02404.X

21 January 2018

Comparative studies of the stereoisomers of glycyrrhetinic acid on anti-inflammatory activities.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02404.X

21 January 2018

Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02404.X

21 January 2018

Medicinal benefits of green tea: Part I. Review of noncancer health benefits

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02404.X

21 January 2018

Vitamin E, oxidative stress, and inflammation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02404.X

21 January 2018

A double-blind placebo-controlled study of ketoconazole + desonide gel combination in the treatment of facial seborrheic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02404.X

21 January 2018

Oral itraconazole for the treatment of seborrhoeic dermatitis: an open, noncomparative trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02404.X

21 January 2018

Itraconazole in the treatment of seborrheic dermatitis: a new treatment modality

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2007.02404.X

21 January 2018

Identifiers

10.1111/J.1468-3083.2007.02404.X

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18269596

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18269596

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46758053&oldid=2129975737"